A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer
Fig 10
Evaluation of proliferation rate of TNBC cells (MDA-MB-231) and luminal-like breast cancer cells (MCF7).
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Evaluation of proliferation rate of TNBC cells (MDA-MB-231) and luminal-like breast cancer cells (MCF7).